NCT04046718已完成不适用
Lipid Profile Response to Electroacupuncture
Ramy Salama Draz1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年8月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- tri-triglycerides (mg/dl) , total cholesterol (mg/dl) , HDL (mg/dl) , LDL (mg/dl)
研究概览
简要总结
sixty female patients suffering from non-alcoholic fatty liver disease were randomly divided into two equal groups group 1 received electroacupuncture stimulation for 6 weeks at special points of stimulation. group 2 was a control group that received nothing without any change in lifestyle and we assed the response of lipid profile post-treatment protocol in both groupes
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 55 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •non alcoholic fatty liver BMI 30-40
排除标准
- •Patients with: (Hepatitis C & b any form of seizure
结局指标
主要结局
tri-triglycerides (mg/dl) , total cholesterol (mg/dl) , HDL (mg/dl) , LDL (mg/dl)
时间窗: 6 weeks
lowering of total lipid profile in study group
次要结局
- weight (kg) , height (m), BMI (kg/m2)(1st week)
研究者
Ramy Salama Draz
Principal Investigator
Cairo University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Electrical Impedance Tomography in Fatty Liver DetectionNon-Alcoholic Fatty Liver DiseaseNCT05189990The University of Hong Kong160
尚未招募
Unknown
se of hsCRP as a marker of severity in patients with non alcoholic fatty liver diseaseCTRI/2024/05/066754Sanju George
Unknown
不适用
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of PrognosisNon-alcoholic Fatty Liver DiseaseNCT03842748Beijing Municipal Administration of Hospitals300
Unknown
不适用
Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis.NASH - Nonalcoholic SteatohepatitisNCT04653311Erasme University Hospital100
Unknown
不适用
Hepaxa Management of Non-alcoholic Fatty Liver DiseaseNon-Alcoholic Fatty Liver DiseaseNon Alcoholic Fatty LiverNASH - Nonalcoholic SteatohepatitisNCT03801577BASF AS50